Issues of peripheral circulation have been increasingly suggested as an underlying cause of musculoskeletal pain in many conditions, including sickle cell anemia and peripheral vascular disease. We have previously shown in our model of transient ischemia and reperfusion (I/R) injury of the forelimb that individual group III and IV muscle afferents display altered chemosensitivity and mechanical thresholds 1 day after injury. Functional alterations corresponded to increased evoked and spontaneous painrelated behaviors and decreased muscle strength and voluntary activity-all actions that echo clinical symptoms of ischemic myalgia. These behavioral and physiological changes appeared to originate in part from the action of increased interleukin 1b (IL1b) in the injured muscles at its upregulated IL1 receptor 1 within the dorsal root ganglion. Here, we describe that two days of voluntary wheel running prior to I/R blocks both injury-induced IL1b enhancement and the subsequent development of ischemic myalgia-like behaviors. Furthermore, the protective effects of 2 days prior exercise on the I/R-evoked increases in pain-related behaviors were also paralleled with systemic injection of the IL1 receptor antagonist during I/R. Interleukin 1 receptor antagonist treatment additionally prevented the I/R-induced changes in mechanical and chemical sensitivity of individual primary muscle afferents. Altogether, these data strengthen the evidence that transient I/R injury sensitizes group III and IV muscle afferents via increased IL1b in the muscles to stimulate ischemic myalgia development. Targeting IL1b may, therefore, be an effective treatment strategy for this insidious type of muscle pain.
Introduction
Musculoskeletal pain is a widely experienced clinical issue, yet many underlying mechanisms have yet to be deciphered. 10, 48 A variety of conditions can result in myalgia, and finding an effective treatment strategy for pain management may depend on the underlying cause. 10 Exercise is commonly recommended for these patient populations, but recent clinical and animal studies have shown mixed results. 3, 6, 10, 38, 41, 51, 54, 63 In some myalgiagenerating conditions, robust exercise interventions may even be detrimental. 3, 43, 44 Thus, determining the appropriate exercise or treatment regimen is critical.
The mechanism through which exercise modulates muscle pain may be due to altered cytokine signaling in the periphery. 3, 21, 41 Exercise is known to increase muscle cytokines, such as the interleukins (ILs) IL-6, IL-10, and interleukin 1b (IL1b). 7, 53, 56 While many proinflammatory mediators may provoke peripheral sensitization, the exercise-induced upregulation of both proinflammatory and antiinflammatory cytokines may not always result in exercise-induced pain in healthy subjects. However, this may not be the case for patients with existing muscle pain conditions, such as ischemic myalgia, which may occur in diseases including sickle cell anemia and peripheral vascular disease. 1, 48, 71, 81 During ischemic conditions, the affected muscle tissue is infiltrated by immune cells 47, 61 that release inflammatory cytokines and growth factors to stimulate repair, 8, 47 similar to those that are modulated during exercise. In our mouse model of transient ischemia and reperfusion (I/R) injury, polymerase chain reaction (PCR) array analysis of the affected muscle tissue showed significant increases in IL1b and glial cell line-derived neurotrophic factor (GDNF) but few other changes in cytokine or growth factor expression. 62 Ischemia and reperfusion also stimulated the upregulation of IL1 receptor 1 (IL1r1), the receptor for IL1b, in the affected dorsal root ganglia (DRG). 61, 62 Furthermore, I/R-induced changes in pain-related behaviors have mimicked common clinical features of ischemic myalgia, 1, 42, 48, 81 such as increased guarding, local mechanical hypersensitivity, decreased muscle strength, and decreased voluntary activity. 61, 62 Afferent-specific inhibition of IL1b/IL1r1 signaling prevented the development of myalgia-like behaviors after I/R. 61 Enhanced IL1b/IL1r1 signaling also modulated the I/Rinduced sensitization of individual group III and IV primary afferents, likely through stimulating the de novo upregulation of acid-sensing ion channel 3 (ASIC3). 46, 61 Acid-sensing ion channel 3 is a known contributor to mechanical 64, 65, 75 and chemical 5, 24, 52 sensation in nociceptive muscle afferents, especially in the case of muscle ischemia 24, 25, 49, 52 as well as in many other muscle pain models. 19, 20, 74, 76, [78] [79] [80] With ex vivo muscle/ nerve/DRG/spinal cord electrophysiology 31 of individual muscle afferents, we previously found that afferent chemosensory and mechanosensory function, as well as response phenotypes, are significantly altered within 1 day after I/R. 61, 62 Clinical studies have shown that IL1r1-targeting drugs designed to reduce inflammation, such as the IL1 receptor antagonist (IL1RA), can also provide pain relief, 22 while other preclinical reports have implicated exercise as a potential regulator of IL1b in neuropathic pain models. 9, 21 Based on these findings, we sought to determine how systemic IL1RA treatment and/or various exercise regimens could modulate the observed behavioral and electrophysiological effects of I/R.
Methods

Animals
Male Swiss Webster mice (Charles River) between age 4 and 8 weeks were used for all experiments. Animals were housed in a pathogen-free, climate-controlled barrier facility in Cincinnati Children's Hospital Medical Center (CCHMC) under the supervision of institutional veterinary services. Mice were kept on a 12-hour light/dark cycle and allowed access to standard rodent chow and water ad libitum. For all injections and surgical procedures, mice were anesthetized with 2% to 3% isofluorane, and for terminal procedures, mice were deeply anesthetized with ketamine (90 mg/kg) and xylazine (10 mg/kg). No additional analgesics were administered in accordance with approved animal use protocols. All procedures were approved and monitored by the CCHMC Institutional Care and Use Committee and were compliant with NIH and AALAC standards.
Ischemia/reperfusion surgery
Ischemia and reperfusion surgeries were performed as previously described 61, 62 immediately after baseline (BL) behavior or 24 hours prior to sacrifice for specific ex vivo or molecular analyses as outlined below. Briefly, the right forelimb of an anesthetized mouse was incised and the brachial artery exposed. A 7-0 silk suture was tied around the brachial artery and the incision closed. After animals were allowed to freely recover in their home cages for 6 hours, the suture was surgically removed and forepaw allowed to reperfuse for 18 hours before any further analysis. In some experiments, a sham surgical procedure was used wherein a suture was placed behind the brachial artery but not tied. As in our previous studies, 61, 62 data from naive and sham animals did not differ in any assay (Table S1 , supplemental digital content, http://links.lww.com/PAIN/A498) and have thus been combined for ease of presentation where indicated.
Drugs
For systemic pharmacological blockade of IL1b/IL1r1, based on previous research 6 and dose-response verification (not shown), anesthetized mice were injected intraperitoneally with 3 mg/kg IL1RA (mouse IL1RA; ProSpec, Rehovot, Israel) both immediately prior to occlusion surgery and again after reperfusion. Comparison groups received I/R surgery and vehicle (H 2 O), and separate control groups received IL1RA or vehicle injections alone at the same intervals. Data from naive, sham, and injection-only conditions were not statistically different in any assay (Tables  S1, S2 , supplemental digital content, http://links.lww.com/PAIN/ A498); therefore, data from these conditions were combined for ease of presentation where indicated.
RNA isolation, reverse transcription, and real-time polymerase chain reaction
Analysis of relative mRNA expression was performed with quantitative real-time PCR (qPCR) as previously described. 34, 45, 62 After transcardial perfusion with a 1:1 solution of sterile 0.9% NaCl:RNAlater (Ambion), the ipsilateral forepaw muscles from age-matched naive and I/R mice with or without 2 days prior voluntary exercise exposure were excised and flash frozen in liquid nitrogen. After tissue homogenization, RNA was isolated from muscle samples using a Qiagen RNeasy fibrous tissues kit according to the manufacturer's protocol. Concentrations of isolated RNA samples were measured, and then DNAse I and Superscript II reverse transcriptase were treated (Invitrogen, Carlsbad, CA). Twenty microgram of cDNA was plated in duplicate reactions with SYBR Green reagents and analyzed on a Step-One real-time PCR machine (Applied Biosystems, Foster City, CA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; forward and reverse primer sequences obtained from Elitt et al. 14 ) was used as an internal control to determine cycle time (Ct) values for all targets. DDCt values for each gene were calculated by subtracting the normalized target gene Cts from those of naive controls. 2
DDCt was used to determine fold change after injury and/or exercise (Applied Biosystems), which were then converted to percent change where 2-fold 5 100% for ease in reporting. Primer sequences for IL1b and GDNF, 62 nerve growth factor (NGF) and artemin, 29 and IL-6 and tumor necrosis factor a (TNFa) 45 have been reported previously.
Behavioral analyses
All behavioral analyses were performed during morning light hours by blinded experimenters as previously described. 58, 61, 62 Assessments of spontaneous pain-like guarding behaviors, as well as evoked measurements of mechanical hypersensitivity (von Frey paw withdrawal) and muscle function (grip strength), were performed immediately prior to occlusion surgery (BL), 24 hours after occlusion (18 hours after reperfusion, D1) and 72 hours after the initial occlusion surgery (D3). Briefly, mice were habituated for 30 minutes in a raised acrylic chamber with a steel mesh bottom prior to assessments of forepaw guarding. Every 5 minutes for 1 hour, each mouse was given a score of 0 to 2 for each forepaw, where 0 5 mouse firmly places paw on mesh, 1 5 mouse paw is touching mesh but is not bearing full weight, and 2 5 mouse holds paw completely above mesh. The average score for all 12 trials on each behavior day was used for analysis. 61, 62, 77 Then, to assess mechanical hypersensitivity, an increasing series of calibrated von Frey filaments (0.07-6 g) were used to stimulate the plantar surface of the forepaw through the mesh of the behavioral chamber. Threshold to withdrawal was recorded for each forepaw 3 times with 5 minutes between each round, and median values were used for analysis. 58, 61, 62 Mice were then placed back in their home cages and individually assayed for forepaw grip strength (in grams) using a grip strength meter (BioSeb; Pinellas Park, FL). The average score of 9 trials (3 rounds of 3 with 5 minutes between rounds) was used for analysis. For experimental paradigms including voluntary wheel running, mice were individually housed with standard food, water, and bedding in chambers accommodating in-cage activity wheels (Lafayette Instruments, Lafayette, Indiana). Velocity and distance traveled were recorded by an automated wheel monitoring system (Lafayette Instruments) in hourly bins. 61 Select exerciseexposed mice were placed in these cages 2 days prior to occlusion surgery (averaging 4197 6 375 m/d across groups), whereas all other wheel-exposed groups were habituated for only 15 to 30 minutes preceding the occlusion. After the initial surgery, mice were housed individually in these cages for the remainder of the study and removed only for reperfusion surgery or behavioral assays at D1 and D3.
Forced running
After the above BL behavioral assessments, I/R surgeries were performed. Immediately after reperfusion surgery, both I/R mice and naive littermates were placed on a 6-lane treadmill (Columbus Instruments, Columbus, OH) at a 0˚incline. After habituation to the apparatus, the speed was slowly increased from 9 to 13 m/minute at 1 m/minute intervals, and then maintained at 13 m/minute until mice had reached a total distance of 500 m traveled in 45 minutes. 58, 70 Twenty-four hours after I/R surgery (D1), guarding, von Frey paw withdrawal, and grip strength assays were repeated. We have previously shown that this particular running protocol alone is not sufficient to induce pain-like behaviors in mice. 58 
Saccharin preference task
To assess the effects of our injury and/or interventions on motivation, individually housed mice were provided two bottles, 1 filled with normal sterile drinking water, and the second containing a 0.1% saccharin solution. 23, 66, 73 During the week prior to I/R surgery, mice were exposed O/N (16 hours) to the two bottles within their home cages on 2 randomly chosen nights to become acclimated to saccharin availability. The bottle positions were swapped between training sessions to reduce any confound produced by side bias, and the second session was used as a BL measurement. After completing these sessions, mice underwent I/R surgeries with or without IL1RA treatments and then were returned to their home cage, where they again had the option of drinking either the saccharin solution or standard water for 16 hours (D1). Bottles were weighed before and after each exposure night, and saccharin preference was calculated as a percentage of the volume of saccharin intake over the total volume of fluid intake. 23 
Protein isolation and western blotting
For each protein sample, the ipsilateral forepaw muscles of a single mouse that was intracardially perfused with an ice cold 0.9% saline solution were excised and prepared as previously described. 29, 30, [32] [33] [34] [35] 61 Samples were homogenized in protein lysis buffer (1% sodium dodecyl sulfate [SDS], 10 mM ph 7.4 TrisHCl, and protease inhibitors [pepstatin, leupeptin, and aprotinin at 1 mg/mL each, 1 mM sodium orthovanadate, and 100 mg/mL phenylmethylsulfonyl fluoride], Sigma-Aldrich, St. Louis, MO), and concentrations were measured by spectroscopy using the DC protein assay (BioRad, Hercules, CA). Immediately prior to electrophoresis on a 12% SDS-polyacrylamide gel, 30 mg of each sample was boiled in denaturing buffer containing SDS and b-mercaptoethanol. Separated proteins were transferred to a polyvinylidene difluoride membrane (Millipore, Billerica, MA) overnight at 4˚C. Membranes were blocked for 60 minutes in 1:1 were used to detect secondary antibody (LiCor) binding of infrared dye-conjugated donkey anti-goat (1:15,000) at 800 nm and donkey anti-chicken at 680 nm (1:20,000) with consistent settings between runs. Immunoreactive bands were analyzed by densitometry using NIH ImageJ software and optical density quantified as fold change normalized to GAPDH (mean 6 SEM).
Ex vivo recording
Electrophysiology was performed as previously described using our ex vivo forepaw muscles/median and ulnar nerves/DRG/ spinal cord recording preparation. 31, 58, 61, 62 Briefly, mice were deeply anesthetized with ketamine/xylazine (see above) and intracardially perfused with ice-cold oxygenated artificial cerebrospinal fluid, then the right forepaw, median and ulnar nerves, C7/C8/T1 DRG, and hemisected spinal cord were dissected out in continuity. To allow for direct probing of muscle receptive fields (RFs) of individual neurons in the C7-T1 DRG, the forepaw skin was removed, and then the preparation was transferred to a recording dish where the artificial cerebrospinal fluid was slowly warmed to 35˚C. Suction electrodes on the median and ulnar nerves provided orthograde search stimuli to isolate electrically responsive afferents, and those with RFs in the muscle were first isolated with a concentric electrode. These afferents were then characterized by applying an increasing series of von Frey filaments (0.07 to 10 g), cold (0˚C) and hot (53˚C) physiological saline, and finally, oxygenated "low" (15 mM lactate, 1 mM adenosine triphosphate [ATP], pH 7.0) and "high" (50 mM lactate, 5 mM ATP, pH 6.6) metabolite mixtures to their RFs to assess mechanosensitivity, thermosensitivity, and chemosensitivity, respectively. Adenosine triphosphate was added to the metabolite solutions immediately before application to prevent degradation. Group III and IV afferents were not significantly different in our samples and were combined for analysis, and cells recorded at the beginning of an ex vivo recording session did not differ from those recorded near the termination of recording. A total of 93 cells were characterized using ex vivo recording in the IL1RA 1 I/ R (54 cells from 11 mice) and vehicle (H2O) 1 I/R conditions (39 cells from 11 mice) here and compared with previously obtained 61, 62 naive data (n 5 120 cells). Data obtained from the electrophysiological preparations were analyzed offline using Spike2 software. For each cell, the peak instantaneous frequency of each response was calculated to approximate the individual cell's maximum potential of firing to a given stimulus. 40 Mechanical thresholds (when detected) and percentage of fiber types responding to our various stimuli were also obtained in our groups.
Immunocytochemistry and cell counting
Immunohistochemistry was performed on C8 DRG from naive, IL1RA 1 I/R, and H 2 O 1 I/R conditions as previously described. 31, 58, 61, 62 Briefly, gelatin-embedded DRG sections (45 mm) were treated with 10 mM citrate buffer (pH 6.0) at 72˚C for antigen retrieval, blocked in Tris-buffered saline with 10% bovine serum albumin, and 0.1% Triton X-100 (Sigma-Aldrich), incubated overnight with primary antibodies for ASIC3 (Guinea Pig anti-ASIC3, 1:2000; Millipore) and P2X3 (Rabbit anti-P2X3, 1: 2000; Thermoscientific, Waltham, MA), and then fluorescently labeled with corresponding secondary antibodies (anti-guinea pig AF647 and anti-rabbit AF594, both 1:400; Jackson ImmunoResearch, West Grove, PA). Stained sections were mounted with Fluoro-Gel (Electron Microscopy Sciences, Hatfield, PA) on gelatin-coated permafrost slides and stored at room temperature. All labeling was characterized on a Leica confocal using sequential scanning and Z-stacks of individual, nonoverlapping DRG sections were scanned at 3 mm intervals for quantification. As previously described, 29, 58, 61 cell counts were performed on 20-mm optical sections generated from these Z-stacks of individual DRG of 3 to 4 different mice per condition to estimate total numbers of ASIC3-positive, P2X3-positive, and ASIC3/P2X3 coexpressing cells. Counts were performed on cells containing nuclei using Neurolucida software to prevent counting cells twice. The average number of positive cells per each DRG was obtained by averaging counts from its 3 nonoverlapping sections, and the average counts per each condition were used for analysis.
Statistical analysis
Data are represented as mean 6 SEM or as percent of cells tested for ex vivo frequency data. All statistical analysis was performed using SigmaPlot 13.0, and data that did not adhere to a normal distribution were transformed before proceeding with parametric statistics or analyzed with a nonparametric analogue. For Western blot, the optical densities of IL1b relative to an internal GAPDH control for each sample were compared via analysis of variance (ANOVA) with Holm-Sidak. Two-way repeated measures ANOVA (time 3 condition) or three-way ANOVA (time 3 condition 3 exercise) was used to analyze behavioral data. One-way ANOVA was used to compare total postinjury distance traveled between groups that had been normalized to the average daily distance from all observed noninjured mice. The Holm-Sidak multiple comparisons correction was applied to all behavioral data requiring post hoc analysis. Gene expression data obtained from real-time quantitative PCR were analyzed using 1-way ANOVA with Holm-Sidak or KruskalWallis 1-way ANOVA on ranks with the Dunn test where appropriate. Differences in phenotype frequency between groups were compared with either x 2 analysis (with Yates correction when applicable) or Fisher exact test. Firing frequencies, thresholds to different stimuli, and cell counts were compared via Kruskal-Wallis 1-way ANOVA on ranks with the Dunn test. For all experiments, critical significance level was defined at P , 0.05.
Results
3.1.
Voluntary exercise prior to ischemia and reperfusion injury to the muscle prevents injury-induced muscle interleukin 1b upregulation and subsequent painrelated behaviors
We have previously reported that IL1b signaling in neurons is crucial for the development of myalgia-like behaviors after I/R injury, 61 and others have shown in a neuropathic pain model that the analgesic properties of moderate exercise are correlated with alterations in peripheral IL1b levels. 21 To compare the role of cytokine and growth factor signaling within the context of exercise or I/R, real-time quantitative PCR was performed on forelimb muscle tissue of mice that had been housed individually in cages with running wheels for 2 days prior to injury and compared with naive and injured mice that were not exposed to running wheels (Fig. 1A) . The mRNA expression of IL-4, 6, 10, and 1b, artemin, NGF, GDNF, and TNFa (Table 1) were all assessed. IL-4, -6, and -10 expression was not detectable across conditions, precluding these genes from analysis. Interleukin 1b mRNA was found to be upregulated within the nonexercised I/R mice compared with both nonexercised naive animals and those with 2 days voluntary exercise exposure (n 5 3-5, P # 0.024), whereas naive and 2 days exercise-exposed animals did not differ (P 5 1.00, Kruskal-Wallis 1-way ANOVA on ranks). After I/R, GDNF was also found to increase over naive or 2 days exercise levels in the muscle (P # 0.041), whereas TNFa showed an I/Rinduced decrease (P # 0.044). Relative expression of NGF was no different between groups (P 5 0.551), but artemin was found to be significantly upregulated after either I/R or exercise when compared with naive animals (I/R: P 5 0.023; 2 days exercise: P 5 0.039).
We then wanted to determine whether this short course of voluntary exercise could prevent injury I/R-induced IL1b upregulation in the muscles and subsequent pain-related behaviors because it was one of the factors specifically enhanced by I/R and inhibited by exercise in injured animals. Here, cohorts of naive or I/R animals were housed individually in cages with running wheels for 2 days prior to injury and compared with groups of naive or I/R mice that were not exposed to running wheels (Fig. 1A) . The naive/sham 1 exercise and I/R 1 exercise groups did not differ in distance traveled during this pretreatment period (naive/sham: 4172 6 490, I/R: 4101 6 668 m/d, P . 0.05). Similar to enhancements in IL1b mRNA, the IL1b protein content of forepaw muscles isolated from either of these 2-day voluntary exercise-exposed groups did not differ from that of nonexercised naive animals 1 day after injury (D1); however, the IL1b in nonexercised I/R animals was significantly elevated compared with all other groups (Fig. 1B, n 5 3-4 , P , 0.01).
In these same exercise and injury conditions, we also assayed 3 ischemic myalgia-like behaviors that we have previously shown to be enhanced at D1 post-I/R 61, 62 : ongoing/spontaneous paw guarding, 77 mechanical hypersensitivity, and muscle weakness. Similar to our previous reports, mice with I/R show increased guarding behaviors in the affected forelimb that persist to day 3 after injury (D3) when compared with all other groups (P , 0.001) as well as to preinjury BL measurements (P , 0.001; Fig. 1C) . Mechanical thresholds at D1 and D3 (Fig. 1D) , along with grip strength at D1 (Fig. 1E) , were also significantly decreased in the I/R group (P , 0.05 compared with BL and all other groups), whereas mice with 2 days prior voluntary exercise exposure showed no I/R-induced changes in any behavioral assay when compared with either BL (P $ 0.22) or naive group measurements (P $ 0.32). An additional group of animals underwent a differing exercise paradigm of short duration forced treadmill running employed immediately after I/R. This mild forced exercise regimen, however, was not effective in mitigating I/Rinduced increases in muscle IL1b (n 5 3-4; P , 0.01 vs naive) or pain-related behaviors (n 5 5-6; P , 0.016) at D1. At D3, forced exercise after injury appeared to prolong I/R-induced mechanical hypersensitivity compared with naive controls (Fig. 2) and all other I/R conditions, regardless of exercise exposure (Fig. S1 , supplemental digital content, http://links.lww.com/PAIN/A498). Forced exercise in mice with I/R was not found to alter grip strength at D3.
Interleukin 1 receptor antagonist attenuates pain-related behaviors caused by ischemia and reperfusion
Because prior exposure to exercise was found to prevent the I/Rinduced increases in both pain-related behaviors and IL1b protein in the muscles at D1 after I/R, we wanted to investigate if targeting IL1b directly could similarly ameliorate these I/R-evoked behavioral changes. Here, we compared the effects of IL1RA and vehicle (H 2 O) treatment on guarding behavior, mechanical hypersensitivity, and grip strength at D1 after I/R when compared with BL measurements (Fig. 3A) . Both groups were similar in BL guarding measurements (P 5 0.864; Fig. 3B ), but vehicle 1 I/R animals showed a dramatic increase in guarding behaviors on D1 compared with either their BL or to IL1RA 1 I/R animals on D1 (P , 0.001). Interleukin 1 receptor antagonist 1 I/R animals did not statistically differ in average guarding scores at BL and D1 (P 5 0.08; 2-way repeated measures ANOVA with Holm-Sidak, time 3 condition interaction P , 0.001). When examining mechanical hypersensitivity (Fig. 3C) , we found that both IL1RA 1 I/R and vehicle 1 I/R animals showed a significant decrease in paw withdrawal threshold when comparing D1 with BL (P , 0.001). Vehicle 1 I/R animals, however, were significantly more hypersensitive than IL1RA-treated mice on D1 (P , 0.001). In addition, grip strength was significantly decreased in both groups (Fig. 3D) , but D1 measurements did not differ between IL1RA or vehicle treatment (P . 0.05).
Interleukin 1 receptor antagonist prevents ischemia and reperfusion-induced alterations in muscle afferents
We wanted to further investigate the effects of IL1RA treatment at the primary afferent level, so we used our ex vivo muscle Values are presented as percent change in expression relative to age-matched naive mice 6 SEM (n 5 3-5 per condition). * P , 0.05 vs naive only. † P , 0.05 vs all other conditions. GDNF, glial cell line-derived neurotrophic factor; IL1b, interleukin 1b; NGF, nerve growth factor; TNFa, tumor necrosis factor a.
preparation to compare the effects of IL1RA or vehicle on afferent plasticity 1 day after I/R (Fig. 4A) . To better understand the relationship between injury and treatment, these data were also compared with previously acquired naive data pooled from our recent studies. 61, 62 We first compared phenotype distribution across conditions to determine the numbers of cells responsive to mechanical, thermal, and chemical stimulation (Fig. 4B ). There were no significant changes in the numbers of thermally Figure 2 . Forced running immediately after reperfusion does not prevent increases in injury-associated pain-related behaviors or in muscle IL1b. (A) Cohorts of age-matched naive and I/R mice underwent a moderate forced treadmill running protocol immediately after reperfusion surgery. (B) As measured by Western blot, the upregulation of muscle IL1b protein expression in forced run I/R vs naive animals was comparable with that seen in nonexercised animals (Fig. 1B) . (C) Paw guarding behaviors were significantly increased at D1 after forced running in animals with I/R (interaction effect of condition 3 time P , 0.001). Similarly, forced running did not affect I/R-induced reductions in mechanical threshold (D; interaction effect of condition 3 time P 5 0.003) or grip strength (E; interaction effect of condition 3 time P 5 0.011), but also did not affect these behaviors in uninjured animals. Data from the nonexercised groups from Fig. 1 have also been included for comparison with forced run conditions. All data are represented as mean 6 SEM. Behavioral data were analyzed via 3-way ANOVA (condition 3 time 3 exercise) with Holm-Sidak, and Western blot data were analyzed using 1-way ANOVA with Holm-Sidak. **P , 0.001 vs BL and uninjured groups, *P , 0.05 vs BL and uninjured groups. ANOVA, analysis of variance; BAO, brachial artery occlusion; BL, baseline; I/R, ischemia and reperfusion; Rep, reperfusion. we found that the population of afferents responding to only low metabolites, only high metabolites, or both low and high metabolites was condition-dependent. Vehicle 1 I/R animals were similar to previous results from I/R conditions 61, 62 in that they exhibited a smaller population of afferents responsive to low metabolites only, and a greater population of afferents responsive to both low and high metabolite solutions (low responders/both responders: naive: 18/7; vehicle 1 I/R: 4/8, P , 0.05; Fig. 4E ). While IL1RA-treated animals had greater numbers of cells responsive to high metabolites only (11/18), this proportion was not found to be statistically significant compared with naive (15/ 40, P 5 0.165) or vehicle 1 I/R (5/31, P 5 1.0). Interleukin 1 receptor antagonist 1 I/R animals also showed a partial recovery from the enhanced firing to low metabolites seen in the vehicle 1 I/R group (P 5 0.033 vs naives), as they were no different from either prior naive data (P 5 0.629) or the vehicle 1 I/R condition (P 5 1.0; Fig. 4F ). Firing to high metabolite solutions was no different between groups (naive: 2.87 6 0.8 Hz, vehicle 1 I/R: 5.33 6 1.4 Hz, IL1RA 1 I/R: 6.14 6 2.2 Hz; P 5 0.611, Kruskal-Wallis 1-way ANOVA on ranks, n 5 8-13).
We also performed cell counts on the affected C7, C8, and T1 DRG from naive, vehicle 1 I/R, and IL1RA 1 I/R mice to quantify the expression of specific pain-related channels (Fig. 5A) previously thought to play a role in I/R-related responses in the DRG. 61 We found that ASIC3 expression was increased in the DRG of vehicle 1 I/R mice (64.11 6 14.23 cells/field of view, P 5 0.018), but not IL1RA 1 I/R mice (13.75 6 2.74, P 5 0.788), relative to naives (8. 83 6 2.35, Fig. 5B ). The increase in P2X3 caused by I/R was not alleviated by IL1RA treatment (naive: 14.92 6 4.19; vehicle 1 I/R: 44.11 6 7.71, P 5 0.007 vs naive; IL1RA 1 I/R: 31 6 3.11, P 5 0.039 vs naive; Fig. 5C ). Coexpression of P2X3 and ASIC3 did not differ between IL1RA 1 I/R animals and naives (Naive: 2.67 6 0.78, IL1RA 1 I/R: 3.5 6 1.22, P 5 1.0), whereas vehicle 1 I/R animals showed significantly more cells coexpressing ASIC3 and P2X3 than found in either of the other groups (26.0 6 6.17; P . 0.05; Fig. 5D ).
Interleukin 1 receptor antagonist treatment in mice with acute running wheel exposure ameliorates ischemia and reperfusion-induced pain-related behaviors
To better understand the relationship between I/R injury, IL1b, and exercise, we also characterized the I/R-induced behavioral changes in IL1RA or vehicle-treated mice that were acutely exposed to a voluntary running wheel (Fig. 6A ) and compared them with noninjured vehicle or IL1RA-injected controls. In this acute exercise exposure paradigm, mice were habituated to the wheel cages for 15 to 20 minutes between BL behavior and occlusion surgery, and their activity was monitored for two days after I/R. We first assessed paw guarding, mechanical hypersensitivity, and grip strength in these other cohorts to confirm I/Rrelated pain-like behaviors in mice acutely exposed to a running wheel. Similar to the previous experiment (Fig. 3) , I/R-induced changes in pain-related behaviors were greatly reduced by IL1RA treatment. Guarding behaviors (Fig. 6B) were significantly increased on D1 in vehicle 1 I/R animals, but this was moderately reduced by IL1RA treatment, so that all groups significantly differed at this time point (P , 0.001). However, IL1RA 1 I/R animals were no different from controls on D3, whereas guarding scores in vehicle 1 I/R mice remained elevated relative to their BL (P 5 0.006) and to controls at D3 (P 5 0.009). Interleukin 1 receptor antagonist treatment blocked the substantial D1 decreases in mechanical paw withdrawal threshold (Fig. 6C ) and grip strength (Fig. 6D) seen in vehicle 1 I/R animals. However, mechanical hypersensitivity was not fully restored to control levels at D3 in IL1RA 1 I/R mice (P 5 0.017).
We then tracked their voluntary activity for two days after I/R surgery because this parameter is another clinically relevant measure often decreased by ischemic myalgia. 48, 81 Distance traveled on the wheel was significantly decreased in vehicle 1 I/R mice on D1 ( Fig. 6E ; P , 0.05 vs other groups), but this deficit was ablated with IL1RA treatment. Furthermore, IL1RA-treated I/R animals also showed a persistent increase in average velocity that surpassed naive and injection control mice ( Fig. 6F ; P , 0.05).
Because we had measured voluntary activity in mice who received 2 days voluntary exercise exposure prior to I/R (shown in Fig. 1) , we compared the total distance traveled after I/R (normalized to the average 2 days distance traveled by naive mice to control for habituation to wheel exposure; Fig.  6G ) between these complimentary data sets. Whereas vehicle 1 I/R animals with acute exposure to voluntary running wheels covered significantly less distance than naives in the 2 days after injury, the animals who had 2 days prior voluntary exercise exposure were protected from the I/R-induced activity decrease (vehicle 1 I/R P # 0.014 vs all other conditions). Altogether, this suggests that the I/R-associated decrease in voluntary activity is not only ablated by IL1RA treatment but also by exercise pretreatment.
Reward motivation is unchanged after interleukin 1 receptor antagonist and/or ischemia and reperfusion
Last, to better understand the effect of motivation in our model of ischemic injury, we used a saccharin preference assay. 23 Sucrose is typically used in this task of anhedonic-like behavior; however, to avoid any potential confounding effects of sucrose on activity level and/or pain, an equally preferred saccharin solution was used. 66, 73 For all groups, BL fluid intake and saccharin preference did not differ (P $ 0.57; data not shown), and neither IL1RA administration nor I/R injury affected saccharin preference (drug P 5 0.918, injury P 5 0.878, drug 3 injury P 5 0.619; Fig.  7A ) or total fluid intake (drug P 5 0.509, injury P 5 0.677, drug 3 injury P 5 0.433; Fig. 7B ) on D1.
Discussion
Transient I/R injury of the forelimb evokes a robust ischemic myalgia-like behavioral phenotype in affected mice. 61, 62 Interleukin 1b/IL1r1 signaling regulates the injury-induced sensitization of primary group III and IV muscle afferents. Specifically, I/R-evoked increases in IL1b within the muscle tissue act at the upregulated IL1r1 in affected DRG to stimulate de novo ASIC3 expression, leading to enhanced chemical and mechanical sensitivity in individual primary muscle afferents, and increased pain-related behaviors in vivo. 61, 62 To better understand the role of IL1b signaling in I/R-induced sensitization, we investigated additional methods of blocking peripheral IL1b action, including voluntary exercise, in this study. Here, we show that prior exposure to 2 days of voluntary exercise completely blocks I/Rinduced increases in both muscle IL1b and pain-related behaviors, in agreement with multiple recent studies showing positive effects of exercise in reducing the pain-related behaviors in various injury models. 9, 21, 39, 57 We also test the effects of a potential pharmacological therapy for ischemic myalgia (IL1RA) on the response properties of individual muscle afferents and pain-like behaviors after I/R.
Interleukin 1b inhibition by exercise and interleukin 1 receptor antagonist
Interleukin 1b, a proinflammatory mediator that has been linked to the development of muscle hyperalgesia, 4, 6, 7, 16, 17 is also important to the generation of an ischemic myalgia-like phenotype in our mouse model of I/R. 61, 62 Here, we confirmed robust increases of IL1b in the affected muscle 1 day after I/R in both nonexercised animals ( Fig. 1) and those submitted to mild, short duration, and forced treadmill running immediately after reperfusion surgery (Fig. 2) . Our previous findings showed that this mild forced running protocol, whether given prior to or during a prolonged occlusive injury, neither attenuated nor enhanced injury-evoked ischemic myalgia-like behaviors. 58 We, therefore, elected to administer this regimen after the I/R injury here. Regardless, animals that had undergone forced treadmill running were not protected from I/R-induced increases in pain-related behaviors. Rather, these animals show increased guarding behaviors in the affected forelimb and decreased mechanical threshold and grip strength, similar to nonexercised mice (Fig. 2,  Fig. S1 , supplemental digital content, http://links.lww.com/PAIN/ A498). Interestingly, whereas a mild forced exercise intervention did little to mitigate the effects of I/R, and may even prolong the effects of injury (Fig. S1 , supplemental digital content, http://links. lww.com/PAIN/A498), prior exposure to 2 days of voluntary wheel running protected against I/R-induced IL1b enhancement ( Figs. 1 and 2 ; Table 1 ). Furthermore, I/R 1 2 days prior exercise mice also failed to develop any I/R-associated pain-related behaviors or show a decrement in voluntary activity after injury (Figs. 1 and 6 ), although I/R animals acutely exposed to the same running wheels in our recent study 61 and in Figure 6 still displayed enhanced ischemic myalgia-like behaviors.
Reviews of exercise therapy for the treatment of chronic pain have suggested that the timing and intensity, and perhaps the voluntary, rather than compulsory nature 57 of an activity regimen strongly influence its beneficence. 1, 3, 10, 27, 38, 44, 51 This may correlate with the differing effects of the various exercise treatments used in this study. Although 2 days of wheel running prior to I/R completely block the injury's painful effects, if an animal begins running immediately before the occlusion through the duration of the study, D1 injury effects will remain just as severe as if they had not run at all (Figs. 1-3, and 6, Fig. S1 , supplemental digital content, http://links.lww.com/PAIN/A498). Interestingly, the presence of this behavioral phenotype coincides with increased IL1b expression within the affected muscle, which animals with 2 days prior exercise do not display. This may not be surprising as physical activity has been increasingly suggested to inoculate against proinflammatory cytokine effects, 54, 55 and within the context of I/R, regulation of disrupted IL1b signaling may contribute to exercise's antinociceptive effects.
Exercise is known to dramatically increase IL1RA within the circulation, and enhances muscle IL1b expression to a lesser extent. 7, 26, 53 Because IL1RA and IL1b have similar binding affinities to IL1r1, the larger increase in IL1RA likely prevents IL1b action. 13 In an effort to untangle the associations between IL1b, exercise, and I/R, we pharmacologically inhibited IL1b action at IL1r1 using a recombinant form of mouse IL1RA. This is similar to a commercially used recombinant human IL1RA employed to combat immune-mediated joint degradation for the treatment of rheumatoid arthritis. Use of this drug has also been shown to relieve rheumatoid arthritis-associated pain. 22, 36 Interleukin 1 receptor antagonist treatment in rodents decreases pain-related behaviors evoked in models of intense swimming exercise, 6 inflammatory pain, 4 bone cancer, 4 and intramuscular acid injection. 69 We found that IL1RA treatment in I/R blocks increased paw guarding and partially restores mechanical thresholds (Fig. 3) . Exogenous IL1RA administration, however, may also decrease the ability of injured tissues to heal, 36, 50 which may account for the drug's lack of effect on I/R-evoked grip strength reduction.
Because of the ability of IL1RA to reduce the ischemic myalgialike behavioral phenotype provoked by I/R, we explored functional effects on individual group III and IV muscle afferents with our ex vivo muscle electrophysiology preparation. 31, 58, 61, 62 The vehicle 1 I/R condition yielded comparable results to our previous studies, namely, lower thresholds to mechanical stimulation and skewed proportions of metabolite responders, when compared with IL1RA-treated animals. There were significantly more mechanically sensitive afferents in the vehicle 1 I/R condition (Fig. 4) than either the IL1RA 1 I/R condition or naive comparison data. Systemic IL1RA administration elicited similar results to our recent study of nerve injection of IL1r1-targeting siRNA during I/R. 61 Furthermore, both treatments are effective in blocking enhanced ASIC3, but not P2X3, expression induced by I/R (Fig. 5) . This suggests that either method is sufficient to inhibit IL1b action at IL1r1 in the peripheral Figure 7 . Reward-seeking behavior is unaffected by I/R and/or IL1RA. Saccharin preference was assayed in an additional cohort of mice with injury and/or injection treatment (n 5 5-6). During the week leading up to I/R surgery, mice of the various conditions were habituated to saccharin exposure during 2 overnight periods. Then, after reperfusion surgery, mice were again provided with both water and saccharin solution. (A) Total liquid intake in these mice over the night after I/ R surgery was no different between groups (P . 0.05). (B) There was no clear effect of IL1RA or I/R on saccharin preference (P . 0.05). Data are represented as mean 6 SEM and were analyzed via 2-way ANOVA (drug 3 injury). ANOVA, analysis of variance; IL1RA, interleukin 1 receptor antagonist; I/R, ischemia and reperfusion. afferents to prevent I/R-induced de novo ASIC3 expression that modulates mechanical and chemical responses in individual primary muscle afferents, leading to increased pain-related behaviors (Figs. 1-5 ). It is important to note that we did not assess the effects of 2 days voluntary exercise on afferents. A full confirmation of its effects on nociceptor function in relation to IL1RA treatment in the future is necessary. In addition, it is possible that exogenous IL1RA might act synergistically with exercise to promote recovery from I/R (Fig. 6) . This combined exposure completely blocked the decreases in mechanical threshold, voluntary activity, and grip strength, and significantly attenuated the increased guarding behaviors observed after I/R, thus providing an improvement over treatment with IL1RA alone. Finally, because of the potential of anhedonia to decrease voluntary activity in our model, we also investigated how reward seeking may be affected by IL1RA and/or I/R. For this, we assessed consumption of a saccharin solution, another natural reward, compared with that of drinking water, in a separate cohort of nonactivity exposed animals (Fig. 7) . A failure to develop a bias toward the saccharin solution can be indicative of anhedonia/depression, but despite an I/R-induced decrease in wheel running, we did not see any differences in saccharin preference in any of our groups, suggesting that the decreased activity levels after I/R are more related to ability than to motivation. However, as alterations in reward pathways may be integral to exercise effects in other conditions, this potential interaction should be considered when using voluntary activity as a means of assessing pain-like behaviors.
Clinical relevance
Muscle pain is a widely experienced clinical problem that can arise from a number of conditions. Exercise is a commonly recommended therapy; however, effective pain management is often etiology-dependent. 10, 51 In diseases such as fibromyalgia, 15 ,37 complex regional pain syndrome, 11, 28 peripheral vascular disease, 1, 42 and chronic fatigue syndrome (CFS), 2,43 myalgia may originate from peripheral perfusion deficits, leading to ischemic-like conditions within affected muscles. Recent evidence is emerging, however, that exercise programs that are effective for analgesia in some patient populations may in fact be hyperalgesic in others. 43, 71 In particular, this may be exacerbating underlying conditions and thus precipitating the prevalence in noncompliance seen in people afflicted with ischemic myalgiarelated disorders. 18, 27, 72 In a recent study of patients with CFS, IL1RA was ineffective in relieving muscle pain symptoms. 60 Species differences and difficulty in generating an appropriate animal model of CFS may account for this discrepancy. However, the clinical trial was performed in women only, and basic research on IL1RA administration in muscle pain models, including the current study, has been performed in males. We have now confirmed IL1b is the integral for the induction of an ischemic myalgia-like phenotype after I/R in male mice; however, there has been a recent bevy of research suggesting that the development of hyperalgesia requires sex-dependent mechanisms of immune response. 67, 68 Because IL1r1 inhibition blocks I/R-induced changes in individual muscle afferents and pain-related behaviors, perhaps these sex differences in IL1RA treatment response are manifested at the level of the primary afferents, implying that the role of IL1b in injury-induced sensitization may be applicable only to males. It will also be important to investigate the effects of exercise on other factors such as GDNF (Table 1) in the future to help determine this. Regardless, because multiple I/R-related conditions disproportionately affect women, 12, 59 ,60 mechanisms of ischemic myalgia generation and maintenance in females should be addressed in future studies.
